Todos Medical Ltd. financial data

Symbol
TOMDF on OTC
Industry
Surgical & Medical Instruments & Apparatus
Location
1 Hamada Street, Rehovot, Israel
State of incorporation
Israel
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2022 - Nov 14, 2022

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 32.7 % -21.3%
Quick Ratio 13.2 % -28.5%
Return On Equity 142 % -38.9%
Return On Assets -273 % -9.77%
Operating Margin -104 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.41B shares +77.5%
Common Stock, Shares, Outstanding 1.35B shares +54.8%
Common Stock, Value, Issued 4.05M USD +56%
Weighted Average Number of Shares Outstanding, Basic 1.28B shares +73.6%
Weighted Average Number of Shares Outstanding, Diluted 1.04B shares +123%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 10.7M USD +89.5%
Revenue from Contract with Customer, Excluding Assessed Tax 10.7M USD +89.5%
Cost of Revenue 6.27M USD +22.1%
Research and Development Expense 306K USD -12.7%
Selling and Marketing Expense 3.46M USD +6.36%
General and Administrative Expense 11.9M USD +96.4%
Operating Income (Loss) -11.2M USD -57.9%
Net Income (Loss) Attributable to Parent -38.8M USD -33.4%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted -0.01 USD/shares +75%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 57K USD -65.7%
Inventory, Net 1.32M USD -30.7%
Other Assets, Current 540K USD +319%
Assets, Current 2.59M USD -39.4%
Property, Plant and Equipment, Net 1.6M USD -38.3%
Operating Lease, Right-of-Use Asset 98K USD -40.2%
Intangible Assets, Net (Excluding Goodwill) 1.5M USD 0%
Goodwill 6.22M USD -19.9%
Other Assets, Noncurrent 1.73M USD
Assets 14.2M USD -17.1%
Accounts Payable, Current 4.12M USD +252%
Accrued Liabilities, Current 1.51M USD
Liabilities, Current 14.2M USD +73.5%
Deferred Income Tax Liabilities, Net 315K USD 0%
Operating Lease, Liability, Noncurrent 82K USD -4.65%
Other Liabilities, Noncurrent 105K USD
Retained Earnings (Accumulated Deficit) -111M USD -54%
Stockholders' Equity Attributable to Parent -31.2M USD -197%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -30.6M USD -192%
Liabilities and Equity 14.2M USD -17.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -1.26M USD +60.3%
Net Cash Provided by (Used in) Financing Activities 1.39M USD -57.4%
Net Cash Provided by (Used in) Investing Activities -244K USD +72.6%
Common Stock, Shares Authorized 10B shares +100%
Common Stock, Shares, Issued 1.35B shares +54.8%
Common Stock, Par or Stated Value Per Share 0.01 ILS/shares
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -115K USD +85.6%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 28K USD
Deferred Tax Assets, Valuation Allowance 7.54M USD
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.23 pure
Deferred Tax Assets, Gross 8.82M USD +6.24%
Payments to Acquire Property, Plant, and Equipment 244K USD -62.9%
Deferred Tax Assets, Operating Loss Carryforwards 8.82M USD +39.3%
Share-based Payment Arrangement, Expense 633K USD